Meyer Handelman Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.2M | Sell |
431,165
-4,716
| -1% | -$275K | 0.81% | 41 |
|
|
2025
Q4 | $23.5M | Sell |
435,881
-39,637
| -8% | -$1.91M | 0.74% | 45 |
|
|
2025
Q3 | $21.4M | Sell |
475,518
-52,438
| -10% | -$2.45M | 0.68% | 47 |
|
|
2025
Q2 | $24.4M | Sell |
527,956
-17,307
| -3% | -$850K | 0.81% | 39 |
|
|
2025
Q1 | $33.3M | Sell |
545,263
-7,905
| -1% | -$461K | 1.16% | 28 |
|
|
2024
Q4 | $31.3M | Sell |
553,168
-10,723
| -2% | -$599K | 1.08% | 31 |
|
|
2024
Q3 | $29.2M | Sell |
563,891
-11,138
| -2% | -$522K | 0.99% | 35 |
|
|
2024
Q2 | $23.9M | Sell |
575,029
-11,605
| -2% | -$519K | 0.84% | 37 |
|
|
2024
Q1 | $31.8M | Sell |
586,634
-25,069
| -4% | -$1.28M | 1.12% | 30 |
|
|
2023
Q4 | $31.4M | Sell |
611,703
-41,160
| -6% | -$2.16M | 1.22% | 30 |
|
|
2023
Q3 | $37.9M | Buy |
652,863
+34,000
| +5% | +$2.08M | 1.53% | 17 |
|
|
2023
Q2 | $39.6M | Buy |
618,863
+21,510
| +4% | +$1.44M | 1.6% | 13 |
|
|
2023
Q1 | $41.4M | Sell |
597,353
-24,700
| -4% | -$1.74M | 1.73% | 13 |
|
|
2022
Q4 | $44.8M | Sell |
622,053
-33,775
| -5% | -$2.55M | 1.87% | 11 |
|
|
2022
Q3 | $46.6M | Sell |
655,828
-11,100
| -2% | -$805K | 2.15% | 8 |
|
|
2022
Q2 | $51.4M | Sell |
666,928
-18,880
| -3% | -$1.44M | 2.2% | 7 |
|
|
2022
Q1 | $50.1M | Buy |
685,808
+5,080
| +0.7% | +$341K | 1.92% | 7 |
|
|
2021
Q4 | $42.4M | Buy |
680,728
+14,890
| +2% | +$873K | 1.58% | 14 |
|
|
2021
Q3 | $39.4M | Sell |
665,838
-2,400
| -0.4% | -$158K | 1.62% | 14 |
|
|
2021
Q2 | $44.7M | Sell |
668,238
-10,900
| -2% | -$711K | 1.76% | 10 |
|
|
2021
Q1 | $42.9M | Buy |
679,138
+18,700
| +3% | +$1.16M | 1.78% | 12 |
|
|
2020
Q4 | $41M | Buy |
660,438
+11,000
| +2% | +$676K | 1.85% | 12 |
|
|
2020
Q3 | $39.2M | Sell |
649,438
-5,900
| -0.9% | -$355K | 1.99% | 10 |
|
|
2020
Q2 | $38.5M | Sell |
655,338
-300
| -0% | -$17.9K | 2.05% | 10 |
|
|
2020
Q1 | $36.5M | Sell |
655,638
-300
| -0% | -$18.3K | 2.24% | 9 |
|
|
2019
Q4 | $42.1M | Buy |
655,938
+2,800
| +0.4% | +$160K | 2.02% | 11 |
|
|
2019
Q3 | $33.1M | Buy |
653,138
+3,600
| +0.6% | +$169K | 1.68% | 15 |
|
|
2019
Q2 | $29.5M | Buy |
649,538
+7,800
| +1% | +$363K | 1.51% | 17 |
|
|
2019
Q1 | $32.7M | Buy |
641,738
+2,900
| +0.5% | +$144K | 1.7% | 16 |
|
|
2018
Q4 | $33.2M | Sell |
638,838
-13,890
| -2% | -$746K | 1.88% | 14 |
|
|
2018
Q3 | $40.5M | Sell |
652,728
-8,400
| -1% | -$498K | 1.98% | 12 |
|
|
2018
Q2 | $36.6M | Buy |
661,128
+800
| +0.1% | +$43.2K | 1.88% | 13 |
|
|
2018
Q1 | $41.8M | Sell |
660,328
-3,180
| -0.5% | -$205K | 2.13% | 10 |
|
|
2017
Q4 | $40.7M | Sell |
663,508
-6,145
| -0.9% | -$384K | 1.95% | 12 |
|
|
2017
Q3 | $42.7M | Sell |
669,653
-135,070
| -17% | -$7.89M | 1.95% | 12 |
|
|
2017
Q2 | $44.8M | Sell |
804,723
-4,100
| -0.5% | -$223K | 1.89% | 10 |
|
|
2017
Q1 | $44M | Buy |
808,823
+3,000
| +0.4% | +$165K | 1.87% | 11 |
|
|
2016
Q4 | $47.1M | Buy |
805,823
+1,690
| +0.2% | +$92.4K | 2.09% | 11 |
|
|
2016
Q3 | $43.4M | Sell |
804,133
-6,200
| -0.8% | -$398K | 1.95% | 11 |
|
|
2016
Q2 | $59.6M | Sell |
810,333
-13,000
| -2% | -$919K | 2.67% | 7 |
|
|
2016
Q1 | $52.6M | Sell |
823,333
-2,400
| -0.3% | -$151K | 2.43% | 7 |
|
|
2015
Q4 | $56.8M | Sell |
825,733
-4,800
| -0.6% | -$317K | 2.69% | 7 |
|
|
2015
Q3 | $49.2M | Sell |
830,533
-9,800
| -1% | -$622K | 2.49% | 7 |
|
|
2015
Q2 | $55.9M | Sell |
840,333
-3,900
| -0.5% | -$257K | 2.56% | 7 |
|
|
2015
Q1 | $54.5M | Sell |
844,233
-5,530
| -0.7% | -$346K | 2.46% | 7 |
|
|
2014
Q4 | $50.2M | Sell |
849,763
-3,090
| -0.4% | -$174K | 2.25% | 9 |
|
|
2014
Q3 | $43.6M | Sell |
852,853
-5,960
| -0.7% | -$298K | 2.03% | 10 |
|
|
2014
Q2 | $41.7M | Sell |
858,813
-3,300
| -0.4% | -$163K | 1.93% | 11 |
|
|
2014
Q1 | $44.8M | Sell |
862,113
-4,600
| -0.5% | -$245K | 2.15% | 8 |
|
|
2013
Q4 | $46.1M | Sell |
866,713
-7,556
| -0.9% | -$385K | 2.23% | 8 |
|
|
2013
Q3 | $40.5M | Sell |
874,269
-2,700
| -0.3% | -$119K | 2.15% | 10 |
|
|
2013
Q2 | $39.2M | Buy |
+876,969
| New | +$38.1M | 2.15% | 10 |
|
Other funds holding BMY
VCM
VPM
Meyer Handelman Company's BMY Position: Q1 2026 in Review
Meyer Handelman Company reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q1 2026, selling an estimated $275K and leaving 431,165 shares worth $26.2M. The position accounts for 0.81% of the portfolio, ranked #41.
Meyer Handelman Company first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $59.6M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Meyer Handelman Company held 431,165 shares of Bristol-Myers Squibb worth $26.2M as of Q1 2026.
- Meyer Handelman Company sold 4,716 Bristol-Myers Squibb shares in Q1 2026, an estimated $275K.
- Bristol-Myers Squibb made up 0.81% of Meyer Handelman Company's portfolio in Q1 2026, its #41 holding.
- Meyer Handelman Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Meyer Handelman Company's Bristol-Myers Squibb position peaked at $59.6M in Q2 2016.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.